




Searching News Database: Clindamycin
HSMN NewsFeed - 26 Oct 2017
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
HSMN NewsFeed - 2 May 2016
Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin(R) Pump Topical Gel
Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin(R) Pump Topical Gel
HSMN NewsFeed - 24 Aug 2015
Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition
Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition
HSMN NewsFeed - 25 Nov 2014
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON(TM) Gel For The Treatment Of Acne Vulgaris
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON(TM) Gel For The Treatment Of Acne Vulgaris
HSMN NewsFeed - 29 Sep 2014
Lumara Health(TM) to be Acquired in Two Separate Transactions for up to $1.107 Billion
Lumara Health(TM) to be Acquired in Two Separate Transactions for up to $1.107 Billion
HSMN NewsFeed - 28 Dec 2012
Perrigo Company Acquires Remaining Stake in Cobrek Pharmaceuticals, Inc. for Approximately $45 Million
Perrigo Company Acquires Remaining Stake in Cobrek Pharmaceuticals, Inc. for Approximately $45 Million
HSMN NewsFeed - 21 Sep 2009
Perrigo Acquires ANDA for Generic Version Duac(R) Gel From KV Pharmaceutical
Perrigo Acquires ANDA for Generic Version Duac(R) Gel From KV Pharmaceutical
HSMN NewsFeed - 27 Aug 2009
Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
HSMN NewsFeed - 6 Mar 2009
Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories
Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories
HSMN NewsFeed - 8 Jul 2008
Stiefel Laboratories, Inc. Commences Tender Offer to Acquire Barrier Therapeutics, Inc.
Stiefel Laboratories, Inc. Commences Tender Offer to Acquire Barrier Therapeutics, Inc.
HSMN NewsFeed - 23 Jun 2008
Barrier Therapeutics, Inc. and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
Barrier Therapeutics, Inc. and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
HSMN NewsFeed - 12 Jun 2007
Immtech and Par Enter Licensing Agreement on Pafuramidine for Treatment of Pneumocystis Pneumonia
Immtech and Par Enter Licensing Agreement on Pafuramidine for Treatment of Pneumocystis Pneumonia
HSMN NewsFeed - 23 Apr 2007
Stiefel Laboratories Moves to Solidify, Enhance Its Leadership Position in Dermatology
Stiefel Laboratories Moves to Solidify, Enhance Its Leadership Position in Dermatology
HSMN NewsFeed - 23 Oct 2006
Connetics Corporation and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
Connetics Corporation and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
HSMN NewsFeed - 19 Sep 2006
FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to-Moderate Atopic Dermatitis
FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to-Moderate Atopic Dermatitis
HSMN NewsFeed - 8 May 2006
Connetics Names Sunil Patel Vice President, Corporate Development and Strategy
Connetics Names Sunil Patel Vice President, Corporate Development and Strategy
Additional items found! 43

Members Archive contains
43 additional stories matching:
Clindamycin
(Password required)
Clindamycin
(Password required)